Instructions for use Flekosteel

Use of Flekosteel Gel Instructions in Germany

Gel for joints and back

Mode of administration and dosage

For adults and children over 12 years old, the drug is applied 2-3 times a day to the skin in the area of inflammation at a dose of 2 g (about 4 cm with the mouth fully open, the tube) with a thin layer and rubbed gently. Single dose of the drug - 2 g. The maximum daily dose of the drug should not exceed 6 g. Use the minimum effective doses for the minimum short course. Use Flekosteel only according to the indications, the method of application and in the doses specified in the instructions.

Indications	Contraindications
post-traumatic inflammation of soft tissues, e. g. B. from sprains, overexertion, bruises, injuries; - rheumatic diseases and swelling of soft tissues (tendovaginitis, bursitis, damage to periarticular tissue, wrist syndrome); - joint pain (finger joints, knees, etc. ) with osteoarthritis; - Back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica) affect the progression of the disease.	- Hypersensitivity to diclofenac or other components of the drug; - Complete or incomplete combination of bronchial asthma, recurrent nasal polyposis of the sinuses, intolerance to salicylates or other NSAIDs (including a history); - pregnancy (III trimester); - breastfeeding - age of children (up to 12 years); - Violation of the integrity of the skin at the intended place of application.

Indications

Contraindications

post-traumatic inflammation of soft tissues, e. g. B. from sprains, overexertion, bruises, injuries; - rheumatic diseases and swelling of soft tissues (tendovaginitis, bursitis, damage to periarticular tissue, wrist syndrome); - joint pain (finger joints, knees, etc. ) with osteoarthritis; - Back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica) affect the progression of the disease.

- Hypersensitivity to diclofenac or other components of the drug; - Complete or incomplete combination of bronchial asthma, recurrent nasal polyposis of the sinuses, intolerance to salicylates or other NSAIDs (including a history); - pregnancy (III trimester); - breastfeeding - age of children (up to 12 years); - Violation of the integrity of the skin at the intended place of application.